同得仕(集团)(00518.HK)就出售深圳福田同得仕大厦订立第二份谅解备忘录
格隆汇9月18日丨同得仕(集团)(00518.HK)发布公告,2019年7月11日,公司与潜在买方订立谅解备忘录,内容有关公司建议出售公司直接全资附属公司升阳(海外)有限公司的全部股份。升阳(海外)持有一座名为“同得仕大厦”的工业大厦,位于深圳福田区北环路市政二号路,该工业大厦乃建于工业用地上,总建筑面积约为1.1万平方米,占地面积约为4319.4平方米。
于2019年9月18日,本公司与潜在买方已订立有关可能出售事项的第二份谅解备忘录,以促成进一步商业磋商。根据谅解备忘录,潜在买方已将可退还的诚意金人民币1000万元支付予由本集团及潜在买方共同控制的银行账户。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.